Progress in topical of application β-blockers in the treatment of infantile hemangioma.

分享到

Link by DOI

关键词: Infantile hemangioma Propranolol Superficial Timolol Topical application 噻吗洛尔婴幼儿血管瘤局部外用普萘洛尔浅表型

摘要: Hemangioma is the most common benign tumor in infants and young children. It is mainly treated by topical and systemic medication, supplemented by laser therapy, depending on the location, size, extent, depth, stage, functional and psychological impact on children. Oral propranolol is currently the first-line treatment for superficial hemangioma.However, topical β-blockers are more likely to be accepted by children’s parents, and their use is gradually increasing.This article reviewed the resear...更多; Hemangioma is the most common benign tumor in infants and young children. It is mainly treated by topical and systemic medication, supplemented by laser therapy, depending on the location, size, extent, depth, stage, functional and psychological impact on children. Oral propranolol is currently the first-line treatment for superficial hemangioma.However, topical β-blockers are more likely to be accepted by children’s parents, and their use is gradually increasing.This article reviewed the research progress of β-blockers in the treatment of infantile hemangiomas in recent years, with the aim to provide a theoretical basis for the treatment of infantile hemangiomas.收起

列表公用js 卡片页统计